822
Views
73
CrossRef citations to date
0
Altmetric
Original Article

Randomized Double-Blind Clinical Trial of Autologous Serum Versus Artificial Tears in Dry Eye Syndrome

, MD, , MD, , MD, MSc, , MD & , MD
Pages 684-688 | Received 27 Jan 2011, Accepted 07 Mar 2012, Published online: 06 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Alejandro Rodriguez-Garcia, Alejandro Babayan-Sosa, Arturo Ramirez-Miranda, Concepcion Santa Cruz-Valdes, Everardo Hernandez-Quintela, Julio C Hernandez-Camarena, Nallely Ramos-Betancourt, Regina Velasco-Ramos & Raul E Ruiz-Lozano. (2022) A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel. Clinical Ophthalmology 16, pages 1331-1355.
Read now
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat & Frank S. Hwang. (2017) Current and emerging therapy of dry eye disease. Part A: pharmacological modalities. Expert Review of Ophthalmology 12:4, pages 269-297.
Read now
Uğur Yılmaz, Erkut Küçük, Çağdaş Koç & Enes Gökler. (2017) Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy. Current Eye Research 42:6, pages 827-831.
Read now
Amir A. Azari, Remzi Karadag, Mozhgan Rezaei Kanavi, Sarah Nehls, Neal Barney, Kyungmann Kim, Walter Longo, Peiman Hematti & Mark Juckett. (2017) Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. Cutaneous and Ocular Toxicology 36:2, pages 152-156.
Read now
José Santiago López-García, Isabel García-Lozano, Luis Rivas, Nuria Ramírez, Maria T. Méndez & Rafaela Raposo. (2016) Stability of Growth Factors in Autologous Serum Eyedrops After Long-Term Storage. Current Eye Research 41:3, pages 292-298.
Read now
Terry G Coursey & Cintia S de Paiva. (2014) Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clinical Ophthalmology 8, pages 1447-1458.
Read now
Kristina Spaniol, Lutz Koerschgen, Oliver Sander, Gesine Koegler & Gerd Geerling. (2014) Comparison of Application Systems for Autologous Serum Eye Drops. Current Eye Research 39:6, pages 571-579.
Read now
Neha Gadaria-Rathod, Kyu-In Lee & Penny A Asbell. (2013) Emerging drugs for the treatment of dry eye disease. Expert Opinion on Emerging Drugs 18:2, pages 121-136.
Read now

Articles from other publishers (65)

Juan Torrent-Burgués. (2023) Tear Film Constituents and Medicines for Eyes Investigated as Langmuir Films. BioNanoScience 13:3, pages 1324-1338.
Crossref
Nicolas G. Quan, Louis Leslie & Tianjing Li. (2023) Autologous Serum Eye Drops for Dry Eye: Systematic Review. Optometry and Vision Science 100:8, pages 564-571.
Crossref
Dian Zhuang, Stuti L. Misra, Odunayo O. Mugisho, Ilva D. Rupenthal & Jennifer P. Craig. (2023) NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease. International Journal of Molecular Sciences 24:13, pages 10866.
Crossref
Matteo Posarelli, Davide Romano, Davide Tucci, Giuseppe Giannaccare, Vincenzo Scorcia, Andrea Taloni, Luca Pagano & Alfredo Borgia. (2023) Ocular-Surface Regeneration Therapies for Eye Disorders: The State of the Art. BioTech 12:2, pages 48.
Crossref
Dominika Wróbel-Dudzińska, Agata Przekora, Paulina Kazimierczak, Agnieszka Ćwiklińska-Haszcz, Ewa Kosior-Jarecka & Tomasz Żarnowski. (2023) The Comparison between the Composition of 100% Autologous Serum and 100% Platelet-Rich Plasma Eye Drops and Their Impact on the Treatment Effectiveness of Dry Eye Disease in Primary Sjogren Syndrome. Journal of Clinical Medicine 12:9, pages 3126.
Crossref
Jayesh Vazirani, Uma Sridhar, Nikhil Gokhale, Venkateswara Rao Doddigarla, Savitri Sharma & Sayan Basu. (2023) Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines. Indian Journal of Ophthalmology 71:4, pages 1357-1363.
Crossref
Neha Kumari, Rakhi Kusumesh, Rekha Kumari, Bibhuti Prassan Sinha & Vivek Singh. (2023) Comparative evaluation of effectiveness of twenty versus fifty percent autologous serum eye drops in treatment of dry eye. Indian Journal of Ophthalmology 71:4, pages 1603-1607.
Crossref
Simran Mangwani-MordaniCourtney F. GoodmanAnat Galor. (2023) Novel Treatments for Chronic Ocular Surface Pain. Cornea 42:3, pages 261-271.
Crossref
Gaetane Nocturne, Marjolaine Gosset & Antoine Rousseau. (2022) Prise en charge de la sécheresse buccale et oculaire. Revue du Rhumatisme Monographies 89:3, pages 173-180.
Crossref
Marina Rodríguez Calvo‐de‐Mora, Cayetano Domínguez‐Ruiz, Francisco Barrero‐Sojo, Gustavo Rodríguez‐Moreno, Cristina Antúnez Rodríguez, Laura Ponce Verdugo, María del Carmen Hernández Lamas, Luisa Hernández‐Guijarro, Jacinto Villalvilla Castillo, Idefonso Fernández‐Baca Casares, Isidro Prat Arrojo, Davide Borroni, Carmen Alba‐Linero, Francisco Zamorano‐Martín, Antonio Moreno‐Guerrero & Carlos Rocha‐de‐Lossada. (2021) Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double‐blind randomized clinical trial. Acta Ophthalmologica 100:2.
Crossref
R. J. Lomas, A. Chandrasekar, C. Macdonald-Wallis, S. Kaye, S. Rauz & F. C. Figueiredo. (2021) Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK. Eye 35:12, pages 3425-3432.
Crossref
Gaetane Nocturne, Marjolaine Gosset & Antoine Rousseau. (2021) Traitements présents et futurs du syndrome sec au cours du syndrome de Gougerot-Sjögren primitif. Revue du Rhumatisme Monographies 88:4, pages 279-286.
Crossref
Juan Torrent-Burgués, Javier Hoyo & Tzanko Tzanov. (2021) Lipid artificial tears at a mimetic ocular interface. Chemistry and Physics of Lipids 238, pages 105087.
Crossref
Passara Jongkhajornpong, Pawin Numthavaj, Thunyarat Anothaisintawee, Kaevalin Lekhanont, Gareth McKay, John Attia & Ammarin Thakkinstian. (2021) Comparison of treatment efficacy between 100% platelet-rich plasma and 100% serum eye drops in moderate-to-severe dry eye disease: a randomised controlled trial protocol. BMJ Open 11:6, pages e048479.
Crossref
Bijnya Birajita Panda, Sumita Mohapatra & Subhabrata Parida. (2020) Update on the role of Eye platelet-rich plasma (E-PRP) in the treatment of ocular surface disorders. Indian Journal of Clinical and Experimental Ophthalmology 6:4, pages 487-496.
Crossref
M. Elizabeth Fini, Shinwu Jeong & Mark R. Wilson. (2020) Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye. International Journal of Molecular Sciences 22:1, pages 116.
Crossref
Adam Muzychuk, Louis RacineMarie-Claude RobertCatherine Birt, Victor Penner, Paul Harasymowycz, Andrew Crichton, Bryce Ford, Patrick Gooi & Mona Harissi-Dagher. (2020) Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists. Journal of Glaucoma 29:12, pages 1162-1172.
Crossref
Madeline Ripa, Sayena Jabbehdari, Ghasem Yazdanpanah, Emoke Lukacs, Brandon Karcher, Omer Iqbal & Charles Bouchard. (2020) The Role of Multisystem Disease in Composition of Autologous Serum tears and ocular surface symptom improvement. The Ocular Surface 18:3, pages 499-504.
Crossref
Alejandra E. Rodriguez, Sandra Gisbert, Antonio Palazón & Jorge L. Alio. (2020) Quantification of Growth Factors and Fibronectin in Diverse Preparations of Platelet-Rich Plasma for the Treatment of Ocular Surface Disorders (E-PRP). Translational Vision Science & Technology 9:6, pages 22.
Crossref
Joanne C.G. Tan, Rachel G. Webb & Denese C. Marks. (2020) Serum growth factor stability in different eye drop packaging systems during storage. Transfusion and Apheresis Science 59:1, pages 102608.
Crossref
Leying Wang, Kai Cao, Zhenyu Wei, Christophe Baudouin, Antoine Labbé & Qingfeng Liang. (2020) Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ophthalmic Research 63:5, pages 443-451.
Crossref
Estela García-Martín, Sagrario Pernía-López, RM Romero Jiménez, Blanca García-Valcárcel, Pilar A Martínez-Ortega & María Sanjurjo-Saez. (2019) The use of autologous serum eye drops for the treatment of ocular surface disorders. European Journal of Hospital Pharmacy 26:6, pages 314-317.
Crossref
M. Kreimei, N. Sorkin, T. Boutin, Allan R. Slomovic, D.S. Rootman & C.C. Chan. (2019) Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort. The Ocular Surface 17:4, pages 743-746.
Crossref
Natanael Levy, Gaelle Ho Wang Yin, Roxane Noharet, Rkia Ghazouane, Fanny Grimaud, Houssein Aboudou, Albert Darque, Nicolas Delmotte, Julie Veran, Louis Hoffart, Daniele Denis, Florence Sabatier & Jeremy Magalon. (2019) A retrospective analysis of characteristic features of responder patients to autologous serum eye drops in routine care. The Ocular Surface 17:4, pages 787-792.
Crossref
Federico Bernabei, Matilde Roda, Marina Buzzi, Marco Pellegrini, Giuseppe Giannaccare & Piera Versura. (2019) Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus. Journal of Clinical Medicine 8:9, pages 1478.
Crossref
Dorota Kopacz & Piotr Maciejewicz. 2019. Chronic Autoimmune Epithelitis - Sjogren's Syndrome and Other Autoimmune Diseases of the Exocrine Glands. Chronic Autoimmune Epithelitis - Sjogren's Syndrome and Other Autoimmune Diseases of the Exocrine Glands.
Víctor García‐Conca, Marta Abad‐Collado, Jose R Hueso‐Abancens, Encarna Mengual‐Verdú, David P Piñero, Fernando Aguirre‐Balsalobre & Julio C Molina. (2018) Efficacy and safety of treatment of hyposecretory dry eye with platelet‐rich plasma. Acta Ophthalmologica 97:2.
Crossref
Cordula DahlmannCordula Dahlmann. 2019. Sicca-Syndrom. Sicca-Syndrom 97 146 .
Alejandra E. Rodríguez & Jorge L. Alió. 2019. Corneal Regeneration. Corneal Regeneration 317 345 .
Michael Marchand, Mona Harissi-Dagher, Marc Germain, Paul Thompson & Marie-Claude Robert. (2018) Serum drops for ocular surface disease: national survey of Canadian cornea specialists. Canadian Journal of Ophthalmology 53:3, pages 266-271.
Crossref
Marina Viegas Moura Rezende Ribeiro, Eurica Adélia Nogueira Ribeiro & Luiz Feliciano Ribeiro. 2018. Plasma Medicine - Concepts and Clinical Applications. Plasma Medicine - Concepts and Clinical Applications.
Tayyeba K. Ali, Allister Gibbons, Cristián Cartes, Siamak Zarei-Ghanavati, Mohamed Gomaa, Ingrid Gonzalez, Astrid E. Gonzalez, Hilal E. Ozturk, Carolina Betancurt & Victor L. Perez. (2018) Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases. American Journal of Ophthalmology 189, pages 65-70.
Crossref
M. Beylerian, M. Lazaro, J. Magalon, J. Veran, A. Darque, F. Grimaud, N. Stolowy, H. Beylerian, F. Sabatier & L. Hoffart. (2018) Collyres de sérum autologue : traitement à long-terme dans le syndrome sec oculaire. Journal Français d'Ophtalmologie 41:3, pages 246-254.
Crossref
Farshad Abedi & Pedram Hamrah. (2018) Corneal Subbasal Nerve Recovery in an Acute Case of Ultraviolet Keratitis Treated with Autologous Serum Eye Drops. Journal of Ophthalmology 2018, pages 1-4.
Crossref
Jorge L. Alio, Alejandra E. Rodriguez, Renan Ferreira-Oliveira, Dominika Wróbel-Dudzińska & Ahmed A. Abdelghany. (2017) Treatment of Dry Eye Disease with Autologous Platelet-Rich Plasma: A Prospective, Interventional, Non-Randomized Study. Ophthalmology and Therapy 6:2, pages 285-293.
Crossref
S Rauz, S-Y Koay, B Foot, S B Kaye, F Figueiredo, M A Burdon, E Dancey, A Chandrasekar & R Lomas. (2017) The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. Eye.
Crossref
Gabriela Dieckmann, Sunali Goyal & Pedram Hamrah. (2017) Neuropathic Corneal Pain. Ophthalmology 124:11, pages S34-S47.
Crossref
Praneetha Thulasi & Ali Reza Djalilian. (2017) Update in Current Diagnostics and Therapeutics of Dry Eye Disease. Ophthalmology 124:11, pages S27-S33.
Crossref
Giuseppe Giannaccare, Piera Versura, Marina Buzzi, Laura Primavera, Marco Pellegrini & Emilio C. Campos. (2017) Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfusion and Apheresis Science 56:4, pages 595-604.
Crossref
Gary D. Novack, Penny Asbell, Stefano Barabino, Michael V.W. Bergamini, Joseph B. Ciolino, Gary N. Foulks, Michael Goldstein, Michael A. Lemp, Stefan Schrader, Craig Woods & Fiona Stapleton. (2017) TFOS DEWS II Clinical Trial Design Report. The Ocular Surface 15:3, pages 629-649.
Crossref
Lyndon Jones, Laura E. Downie, Donald Korb, Jose M. Benitez-del-Castillo, Reza Dana, Sophie X. Deng, Pham N. Dong, Gerd Geerling, Richard Yudi Hida, Yang Liu, Kyoung Yul Seo, Joseph Tauber, Tais H. Wakamatsu, Jianjiang Xu, James S. Wolffsohn & Jennifer P. Craig. (2017) TFOS DEWS II Management and Therapy Report. The Ocular Surface 15:3, pages 575-628.
Crossref
Ronald Mauricio Sanchez-AvilaJesus Merayo-LlovesAna Cristina RiestraEduardo AnituaFrancisco MuruzabalGorka OriveLuis Fernández-Vega. (2017) The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome. Journal of Ocular Pharmacology and Therapeutics 33:5, pages 391-399.
Crossref
Qing Pan, Adla Angelina, Michael Marrone, Walter J Stark & Esen K Akpek. (2017) Autologous serum eye drops for dry eye. Cochrane Database of Systematic Reviews 2017:2.
Crossref
Wendy Chao, Carlos Belmonte, José M. Benitez del Castillo, Anthony J. Bron, Harminder S. Dua, Kelly K. Nichols, Gary D. Novack, Stefan Schrader, Mark D. Willcox, James S. Wolffsohn & David A. Sullivan. (2016) Report of the Inaugural Meeting of the TFOS i2 = initiating innovation Series: Targeting the Unmet Need for Dry Eye Treatment. The Ocular Surface 14:2, pages 264-316.
Crossref
J. Torrent-Burgués. (2016) Langmuir films study on lipid-containing artificial tears. Colloids and Surfaces B: Biointerfaces 140, pages 185-188.
Crossref
Jesús Merayo-Lloves, Ronald M. Sanchez-Avila, Ana C. Riestra, Eduardo Anitua, Leire Begoña, Gorka Orive & Luis Fernandez-Vega. (2016) Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye. Ophthalmic Research 56:2, pages 68-73.
Crossref
Antonio M. Fea, Vittoria Aragno, Valeria Testa, Federica Machetta, Simone Parisi, Sergio D’Antico, Roberta Spinetta, Enrico Fusaro & Federico M. Grignolo. (2016) The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study. BioMed Research International 2016, pages 1-10.
Crossref
Nishant G Soni & Bennie H Jeng. (2016) Blood-derived topical therapy for ocular surface diseases. British Journal of Ophthalmology 100:1, pages 22-27.
Crossref
Aileen Sy, Kieran S. O’Brien, Margaret P. Liu, Puja A. Cuddapah, Nisha R. Acharya, Thomas M. Lietman & Jennifer Rose-Nussbaumer. (2015) Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). BMC Ophthalmology 15:1.
Crossref
Ryan B. Nugent & Graham A. Lee. (2015) Ophthalmic use of blood-derived products. Survey of Ophthalmology 60:5, pages 406-434.
Crossref
Teruo Nishida, Makoto Inui & Motoyoshi Nomizu. (2015) Peptide therapies for ocular surface disturbances based on fibronectin–integrin interactions. Progress in Retinal and Eye Research 47, pages 38-63.
Crossref
Nisreen S. Ezuddin, Karam A. Alawa & Anat Galor. (2015) Therapeutic Strategies to Treat Dry Eye in an Aging Population. Drugs & Aging 32:7, pages 505-513.
Crossref
Amir A. Azari & Christopher J. Rapuano. (2015) Autologous Serum Eye Drops for the Treatment of Ocular Surface Disease. Eye & Contact Lens: Science & Clinical Practice 41:3, pages 133-140.
Crossref
Maria Rosaria De Pascale, Michele Lanza, Linda Sommese & Claudio Napoli. (2015) Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis. Journal of Ophthalmology 2015, pages 1-14.
Crossref
Maria Rosaria De Pascale, Linda Sommese, Amelia Casamassimi & Claudio Napoli. (2015) Platelet Derivatives in Regenerative Medicine: An Update. Transfusion Medicine Reviews 29:1, pages 52-61.
Crossref
Simon E. Skalicky, Con Petsoglou, Avinash Gurbaxani, Clare L. Fraser & Peter McCluskey. 2015. Studies on the Cornea and Lens. Studies on the Cornea and Lens 115 129 .
Munira Hussain, Roni M. Shtein, Alan Sugar, H. Kaz Soong, Maria A. Woodward, Karen DeLoss & Shahzad I. Mian. (2014) Long-term Use of Autologous Serum 50% Eye Drops for the Treatment of Dry Eye Disease. Cornea 33:12, pages 1245-1251.
Crossref
Hui Lin & Samuel C. Yiu. (2014) Dry eye disease: A review of diagnostic approaches and treatments. Saudi Journal of Ophthalmology 28:3, pages 173-181.
Crossref
Ali Riza Cenk Celebi, Cemalettin Ulusoy & G. Ertugrul Mirza. (2014) The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefe's Archive for Clinical and Experimental Ophthalmology 252:4, pages 619-626.
Crossref
Francesco Semeraro, Eliana Forbice, Osvaldo Braga, Alessandro Bova, Attilio Di Salvatore & Claudio Azzolini. (2014) Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies. BioMed Research International 2014, pages 1-11.
Crossref
Anat Galor. 2014. Advances in Medical and Surgical Cornea. Advances in Medical and Surgical Cornea 1 10 .
Qing Pan, Adla Angelina, Andrea Zambrano, Michael Marrone, Walter J Stark, Thomas Heflin, Li Tang & Esen K Akpek. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Norihiko YokoiDuna Raoof-DaneshvarRoni M Shtein. 2013. Dry Eye Syndrome: Basic and Clinical Perspectives. Dry Eye Syndrome: Basic and Clinical Perspectives 50 59 .
Simon E. Skalicky, Con Petsoglou, Avinash Gurbaxani, Clare L. Fraser & Peter McCluskey. (2012) New Agents for Treating Dry Eye Syndrome. Current Allergy and Asthma Reports 13:3, pages 322-328.
Crossref
Kaevalin Lekhanont, Passara Jongkhajornpong, Lulin Choubtum & Varintorn Chuckpaiwong. (2013) Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery. BioMed Research International 2013, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.